CAS 13122-87-7

GSK-256066

CAS : 13122-87-7

GSK-256066 is a potent inhibitor of kinases that has been shown to induce apoptosis in Chinese hamster ovary cells. This compound has potential as an anticancer agent due to its ability to inhibit the growth of tumor cells. GSK-256066 is an analog of a medicinal compound and has been found to be effective against several types of cancer, including breast, lung, and prostate cancer. The kinase inhibition activity of GSK-256066 is thought to be responsible for its anticancer effects by preventing the phosphorylation of proteins involved in cell division and growth. GSK-256066 is also being studied as a potential treatment for other diseases such as Alzheimer's disease and diabetes. It has been detected in human urine after administration, indicating that it may have potential as a therapeutic agent.

Formule : C₂₇H₂₆N₄O₅S

Degré de pureté : Min. 95%

Masse moléculaire : 518.6 g/mol

Ref: 3D-NAA12287

GSK-256066

CAS : 13122-87-7

GSK-256066 is a PDE4 inhibitor.

Formule : C₂₇H₂₈N₂O₅

Couleur et forme : Solid

Masse moléculaire : 460.52

Ref: TM-T70995